中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 11
Nov.  2021
Turn off MathJax
Article Contents

Pathological features and pathological diagnosis of drug-induced liver injury

DOI: 10.3969/j.issn.1001-5256.2021.11.005
Research funding:

General Project of National Natural Science Foundation of China (81970454)

  • Received Date: 2021-09-15
  • Accepted Date: 2021-09-15
  • Published Date: 2021-11-20
  • Based on liver histology, drug-induced liver injury (DILI) is classified as various pathological types of inflammatory necrosis, cholestasis, fatty degeneration and fatty liver disease, vascular injury, and minimal lesion. Histopathological examination is required for further differential diagnosis in suspected cases of DILI, liver injury that cannot be explained by DILI monogenesis, DILI cases with a history of exposure to various drugs in which the specific drug causing liver injury cannot be determined, DILI cases with unsatisfactory treatment outcome, and chronic DILI, and histopathological examination can also be used to evaluate the severity and prognosis of DILI. Since liver lesions are unevenly distributed in DILI, adequate tissue samples are needed to reduce sampling error. The histopathological manifestation of liver injury diseases has the features of "one cause with multiple results and one result with multiple causes", and a combination of pathological examination and clinical symptoms can help to make a confirmed diagnosis, suggesting that clinicopathological discussion is of great importance in the histological diagnosis of DILI.

     

  • loading
  • [1]
    GASMI B, KLEINER DE. Liver histology: Diagnostic and prognostic features[J]. Clin Liver Dis, 2020, 24(1): 61-74. DOI: 10.1016/j.cld.2019.09.004.
    [2]
    KLEINER DE, CHALASANI NP, LEE WM, et al. Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations[J]. Hepatology, 2014, 59(2): 661-670. DOI: 10.1002/hep.26709.
    [3]
    TSUTSUI A, HARADA K, TSUNEYAMA K, et al. Histopathological analysis of autoimmune hepatitis with "acute" presentation: Differentiation from drug-induced liver injury[J]. Hepatol Res, 2020, 50(9): 1047-1061. DOI: 10.1111/hepr.13532.
    [4]
    COHEN JV, DOUGAN M, ZUBIRI L, et al. Liver biopsy findings in patients on immune checkpoint inhibitors[J]. Mod Pathol, 2021, 34(2): 426-437. DOI: 10.1038/s41379-020-00653-1.
    [5]
    BHUSHAN B, APTE U. Liver Regeneration after acetaminophen hepatotoxicity: Mechanisms and therapeutic opportunities[J]. Am J Pathol, 2019, 189(4): 719-729. DOI: 10.1016/j.ajpath.2018.12.006.
    [6]
    DAKHOUL L, GHABRIL M, CHALASANI N. Drug-induced chronic liver injury[J]. J Hepatol, 2018, 69(1): 248-250. DOI: 10.1016/j.jhep.2018.01.001.
    [7]
    BONKOVSKY HL, KLEINER DE, GU J, et al. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements[J]. Hepatology, 2017, 65(4): 1267-1277. DOI: 10.1002/hep.28967.
    [8]
    GOODMAN ZD. Phenotypes and pathology of drug-induced liver disease[J]. Clin Liver Dis, 2017, 21(1): 89-101. DOI: 10.1016/j.cld.2016.08.006.
    [9]
    LEE B, JUNG EA, YOO JJ, et al. Prevalence, incidence and risk factors of tamoxifen-related non-alcoholic fatty liver disease: A systematic review and meta-analysis[J]. Liver Int, 2020, 40(6): 1344-1355. DOI: 10.1111/liv.14434.
    [10]
    CAYET S, PASCO J, DUJARDIN F, et al. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation[J]. Eur J Radiol, 2017, 94: 180-190. DOI: 10.1016/j.ejrad.2017.06.025.
    [11]
    CZECZOK TW, van ARNAM JS, WOOD LD, et al. The almost-normal liver biopsy: Presentation, clinical associations, and outcome[J]. Am J Surg Pathol, 2017, 41(9): 1247-1253. DOI: 10.1097/PAS.0000000000000881.
    [12]
    YANG YF. Road map of diagnosis in patients with unknown causes[J]. J Pract Hepatol, 2018, 21(1): 1-3. DOI: 10.3969/j.issn.1672-5069.2018.01.001.

    杨永峰. 不明原因肝病诊断思路[J]. 实用肝脏病杂志, 2018, 21(1): 1-3. DOI: 10.3969/j.issn.1672-5069.2018.01.001.
    [13]
    KLEINER DE. The histopathological evaluation of drug-induced liver injury[J]. Histopathology, 2017, 70(1): 81-93. DOI: 10.1111/his.13082.
    [14]
    YU HY, GUO YY, YANG YF. Amoxicillin induced bile duct deletion drug-induced liver injury: A case report[J]. Chin Hepatol, 2018, 23(12): 1155-1156. DOI: 10.14000/j.cnki.issn.1008-1704. 2018.12.039.

    俞海英, 郭银燕, 杨永峰. 阿莫西林导致胆管缺失型药物性肝损伤1例[J]. 肝脏, 2018, 23(12): 1155-1156. DOI: 10.14000/j.cnki.issn.1008-1704.2018.12.039.
    [15]
    LIU HL, YANG YF, XIONG QF, et al. Etiological analysis of hepatopathy of unknown etiology in 470 cases undergoing routine liver biopsy examination[J]. Chin J Hepatol, 2019, 27(11): 885-889. DOI: 10.3760/cma.j.issn.1007-3418.2019.11.012.

    刘红丽, 杨永峰, 熊清芳, 等. 470例行肝穿刺活组织检查的不明原因肝病的病因分析[J]. 中华肝脏病杂志, 2019, 27(11): 885-889. DOI: 10.3760/cma.j.issn.1007-3418.2019.11.012.
    [16]
    KLEINER DE, CHALASANI NP, LEE WM, et al. Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations[J]. Hepatology, 2014, 59(2): 661-670. DOI: 10.1002/hep.26709.
    [17]
    COLLOREDO G, GUIDO M, SONZOGNI A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease[J]. J Hepatol, 2003, 39(2): 239-244. DOI: 10.1016/s0168-8278(03)00191-0.
    [18]
    NEUBERGER J, PATEL J, CALDWELL H, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology[J]. Gut, 2020, 69(8): 1382-1403. DOI: 10.1136/gutjnl-2020-321299.
    [19]
    VIBHAKORN S, CHOLONGITAS E, KALAMBOKIS G, et al. A comparison of four- versus three-pass transjugular biopsy using a 19-G Tru-Cut needle and a randomized study using a cassette to prevent biopsy fragmentation[J]. Cardiovasc Intervent Radiol, 2009, 32(3): 508-513. DOI: 10.1007/s00270-008-9412-7.
    [20]
    KLEINER DE. Drug-induced liver injury: The hepatic pathologist's approach[J]. Gastroenterol Clin North Am, 2017, 46(2): 273-296. DOI: 10.1016/j.gtc.2017.01.004.
    [21]
    YANG YF. Improve the knowledge of liver pathology and related skills among clinicians engaged in hepatology[J]. 2018, 34(11): 2267-2270. DOI: 10.3969/j.issn.1001-5256.2018.11.001.

    杨永峰. 提高肝病学科临床医师的病理修养[J]. 临床肝胆病杂志, 2018, 34(11): 2267-2270. DOI: 10.3969/j.issn.1001-5256.2018.11.001.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (789) PDF downloads(209) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return